1019 / 1631
Conclusions
•
P-BH
provides the maximum dosimetric benefit
to the heart, LV, and
lungs compared to all other plans
•
Consider extent of disease when choosing RT modality
•
IMRT-
BH
was comparable to P-
FB
and IMPT-
FB
plans
(with exception
of body and esophageal dose)
•
IMPT-FB did not improve doses compared to P-BH
•
P-BH currently theoretical at our institution